Healthcare


 Kalkine: AnteoTech (ASX:ADO) Accelerates Growth with Surge in Life Sciences Revenue and Strategic Global Progress

Kalkine: AnteoTech (ASX:ADO) Accelerates Growth with Surge in Life Sciences Revenue and Strategic Global Progress

June 12, 2025 06:09 PM AEST| By Team Kalkine Media

Highlights,AnteoTech (ADO) expects 130% growth in Life Sciences sales for FY2025,Serum Institute places major order for AnteoBind™ valued at A$213,000,Key R&D milestones achieved despite delays in some global projects,AnteoTech (ASX:ADO), a leading n...

 Kalkine: EVE Health Group (ASX:EVE) Strengthens Position in Regulated Healthcare with Nextract Acquisition

Kalkine: EVE Health Group (ASX:EVE) Strengthens Position in Regulated Healthcare with Nextract Acquisition

June 12, 2025 06:06 PM AEST| By Team Kalkine Media

Highlights,EVE completes strategic acquisition of Nextract Pty Ltd,New therapeutic products target major global health markets,Leadership reshuffle supports growth in regulated healthcare,EVE Health Group (ASX:EVE) has officially finalized the acquis...

 Kalkine: ASX 200 Biotech Firm Mesoblast Gains Momentum Following FDA Developments

Kalkine: ASX 200 Biotech Firm Mesoblast Gains Momentum Following FDA Developments

June 12, 2025 04:33 PM AEST| By Team Kalkine Media

Highlights,Mesoblast (ASX:MSB) reports positive discussions with the US FDA on cardiac treatment Revascor,Upcoming FDA meeting scheduled for Ryoncil’s adult trial in graft versus host disease,Progress across two key programs supports sentiment in the...

 Kalkine: Monash IVF Faces ASX 200 Scrutiny After Second Embryo Transfer Error

Kalkine: Monash IVF Faces ASX 200 Scrutiny After Second Embryo Transfer Error

June 12, 2025 02:40 PM AEST| By Team Kalkine Media

Highlights,Monash IVF Group Ltd (ASX:MVF) confirms second embryo transfer issue, prompting market response,Incident occurred at Clayton lab, following a separate Brisbane case disclosed earlier,Independent investigation expanded to include both incid...

 Kalkine: Cochlear Launches Smart Implant System as ASX 200 Healthcare Stock Updates FY25 Outlook

Kalkine: Cochlear Launches Smart Implant System as ASX 200 Healthcare Stock Updates FY25 Outlook

June 12, 2025 02:06 PM AEST| By Team Kalkine Media

Highlights,Cochlear Ltd (ASX:COH) introduces Nucleus Nexa System with firmware upgrade functionality,FY25 earnings guidance revised amid slower Services segment performance,Cochlear Ltd (ASX:COH), a key healthcare stock listed on the,ASX 200,,,ASX 10...

 Kalkine: Monash IVF (ASX:MVF) Faces Leadership Shakeup Amid Embryo Error Incidents

Kalkine: Monash IVF (ASX:MVF) Faces Leadership Shakeup Amid Embryo Error Incidents

June 12, 2025 01:50 PM AEST| By Team Kalkine Media

Highlights,CEO steps down following back-to-back embryo mix-ups,Acting CEO appointed as company reassures financial outlook,Renewed calls for national IVF regulation intensify,Monash IVF Group Ltd (ASX:MVF), a member of the ASX300, is under the spotl...

 Kalkine: Monash IVF (ASX:MVF) Rises as CEO Steps Down Amid Second Embryo Mix-Up

Kalkine: Monash IVF (ASX:MVF) Rises as CEO Steps Down Amid Second Embryo Mix-Up

June 12, 2025 01:46 PM AEST| By Team Kalkine Media

Highlights,Monash IVF CEO exits following second embryo transfer error,Shares surge,nearly 8%,after leadership change,Public demand rises for national IVF regulation,Shares of fertility services provider Monash IVF (ASX:MVF) surged following the resi...

 Kalkine: Cochlear (ASX:COH) Shares Stabilise Amid Guidance Update and Product Launch in ASX300

Kalkine: Cochlear (ASX:COH) Shares Stabilise Amid Guidance Update and Product Launch in ASX300

June 12, 2025 12:34 PM AEST| By Team Kalkine Media

Highlights,Cochlear updates FY guidance; stock recovers early losses,New product launch aims to lift future revenue streams,ASX300 spotlight: Innovation counters market slowdown,Cochlear (ASX:COH), a key player in the hearing implant space and a cons...

 Kalkine: Cettire (ASX:CTT) Shares Plunge Amid Weak Trading Update; ASX300 Firm Faces Steep Cash Burn

Kalkine: Cettire (ASX:CTT) Shares Plunge Amid Weak Trading Update; ASX300 Firm Faces Steep Cash Burn

June 12, 2025 12:30 PM AEST| By Team Kalkine Media

Highlights,Cettire's,Q4 performance fell short of EBITDA expectations,Revenue and cash levels declined sharply in April and May,Concerns grow over potential equity raise to restore capital buffer,Luxury online fashion retailer,Cettire (ASX:CTT),saw a...

 Kalkine : ASX 200 Stock Monash IVF Rebounds After Embryo Mix-Up Concerns

Kalkine : ASX 200 Stock Monash IVF Rebounds After Embryo Mix-Up Concerns

June 11, 2025 05:37 PM AEST| By Team Kalkine Media

Highlights,Monash IVF shares regain ground after a sharp decline on Tuesday,Macquarie labels the share price fall as an overreaction,Ongoing support for IVF sector expected despite operational errors,Monash IVF Group Ltd (ASX:MVF), listed on the,ASX...

 Kalkine: ASX 200 Biotech Stock CU6 Surges on Promising Trial Data

Kalkine: ASX 200 Biotech Stock CU6 Surges on Promising Trial Data

June 11, 2025 04:17 PM AEST| By Team Kalkine Media

Highlights,Clarity Pharmaceuticals Ltd (ASX:CU6) reported successful Phase II trial results for neuroendocrine tumour diagnostics,Company advancing targeted copper theranostics for cancer using SAR Technology Platform,ASX 200 index gains amid renewed...

 Kalkine: Noxopharm's Sofra™ Platform Gains Momentum with BioRay Study in ASX300 Biotech Space

Kalkine: Noxopharm's Sofra™ Platform Gains Momentum with BioRay Study in ASX300 Biotech Space

June 11, 2025 03:30 PM AEST| By Team Kalkine Media

Highlights,Noxopharm’s Sofra™ tech validated through BioRay testing,Promising inflammation-fighting results from oligonucleotide platform,Collaboration boosts Sofra’s potential as versatile ASX300 biotech innovation,Noxopharm Limited (ASX:NOX), a cli...

 Kalkine: PME Shares Surge in ASX200: Exploring Growth, Tech & Ethical Edge in Healthcare

Kalkine: PME Shares Surge in ASX200: Exploring Growth, Tech & Ethical Edge in Healthcare

June 11, 2025 03:20 PM AEST| By Team Kalkine Media

Highlights,PME shares have risen over 12% YTD amid healthcare sector momentum,Visage technology positions Pro Medicus as a global leader in radiology software,Ethical and growth-focused exposure within the ASX200 healthcare ecosystem,The healthcare s...

 Kalkine: Cyclopharm Gets Technegas Patent Extension, Boosting ASX200 Growth Story

Kalkine: Cyclopharm Gets Technegas Patent Extension, Boosting ASX200 Growth Story

June 11, 2025 01:57 PM AEST| By Team Kalkine Media

Highlights,Cyclopharm,secures US patent extension for,Technegas,to 2031,Strengthens exclusivity in world’s largest healthcare market,Bolsters,commercialisation,pathway in lung imaging space,Cyclopharm (ASX:CYC) has achieved a critical milestone in it...

 Kalkine: Prescient Therapeutics Leads ASX200 Biotech Push With Innovations in Cancer Therapy (ASX:PTX)

Kalkine: Prescient Therapeutics Leads ASX200 Biotech Push With Innovations in Cancer Therapy (ASX:PTX)

June 11, 2025 11:19 AM AEST| By Team Kalkine Media

Highlights,PTX-100 targets high-mortality cancers linked to RAS mutations.,Prescient’s,cell therapies aim to enhance CAR-T effectiveness.,Fast-track designations support regulatory progress.,Prescient Therapeutics (ASX:PTX), a clinical-stage biotechn...

 Kalkine: ASX 200 Eyes Innovation as Lyrebird Health Secures New Capital for AI Scribe Tool

Kalkine: ASX 200 Eyes Innovation as Lyrebird Health Secures New Capital for AI Scribe Tool

June 10, 2025 03:22 PM AEST| By Team Kalkine Media

Highlights,Lyrebird Health completes funding round to strengthen AI-based clinical documentation platform,Backing from Five V Capital and Octopus Ventures supports global scale-up and regulatory compliance,Integration efforts continue with electronic...

 Kalkine: Botanix (ASX:BOT) Strengthens Commercial Push with A$48M Facility Backing in ASX200 Spotlight

Kalkine: Botanix (ASX:BOT) Strengthens Commercial Push with A$48M Facility Backing in ASX200 Spotlight

June 10, 2025 02:40 PM AEST| By Team Kalkine Media

Highlights,Botanix secures A$48M debt facility to fuel commercial rollout,Capital directed toward Sofdra™ launch and platform growth,Strategic financial moves bolster Botanix’s ASX200 presence,Botanix Pharmaceuticals Ltd (ASX:BOT), a clinical-stage p...

 Kalkine: ASX 200 Watch: INOVIQ (ASX:IIQ) Updates on Cash Position Amid Sector Pressures

Kalkine: ASX 200 Watch: INOVIQ (ASX:IIQ) Updates on Cash Position Amid Sector Pressures

June 10, 2025 02:26 PM AEST| By Team Kalkine Media

Highlights,INOVIQ (ASX:IIQ) operates within the biotech sector, focusing on diagnostics and clinical development technologies,Company outlines updated cash position and reduced outflows over the past financial year,Sector sentiment influenced by broa...

 Kalkine: EZZ Life Science Secures $21M South-East Asia Deal, Boosting ASX200 Exposure

Kalkine: EZZ Life Science Secures $21M South-East Asia Deal, Boosting ASX200 Exposure

June 10, 2025 02:21 PM AEST| By Team Kalkine Media

Highlights,EZZ inks $21 million South-East Asia deal,ROFA to distribute across Thailand, Vietnam, Singapore,US manufacturing to strengthen global presence,EZZ Life Science Holdings (ASX:EZZ) has taken a significant leap forward in its international e...

 Kalkine: Monash IVF Faces Second Embryo Error in 2025, Stirring ASX200 Concerns

Kalkine: Monash IVF Faces Second Embryo Error in 2025, Stirring ASX200 Concerns

June 10, 2025 01:05 PM AEST| By Team Kalkine Media

Highlights,Monash IVF (MVF) reported a second embryo transfer error this year.,The company is introducing stricter verification and oversight.,MVF,remains,part of broader conversations in the ASX200 healthcare sector.,Shares of Monash IVF Group Ltd (...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.